Clinical utility of single-beat E/e' obtained by simultaneous recording of flow and tissue Doppler velocities in atrial fibrillation with preserved systolic function.
暂无分享,去创建一个
M. Akaike | T. Wakatsuki | T. Iwase | K. Kusunose | M. Sata | H. Yamada | K. Koshiba | S. Nishio | S. Yagi | K. Yamaguchi | T. Soeki | Toshiyuki Niki | Y. Taketani | N. Tomita
[1] C. Appleton,et al. Echocardiographic assessment of left ventricular diastolic function and filling pressure in atrial fibrillation. , 2008, The American journal of cardiology.
[2] C. Landolfo,et al. Derivation and validation of a diagnostic model for the evaluation of left ventricular filling pressures and diastolic function using mitral annulus tissue Doppler imaging. , 2008, American heart journal.
[3] Ç. Yenisey,et al. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients , 2008, The International Journal of Cardiovascular Imaging.
[4] M. Matsuzaki,et al. Ratio of early transmitral velocity to lateral mitral annular early diastolic velocity has the best correlation with wedge pressure following cardiac surgery. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[5] M. Zile,et al. Left ventricular end-diastolic volume is normal in patients with heart failure and a normal ejection fraction: a renewed consensus in diastolic heart failure. , 2007, Journal of the American College of Cardiology.
[6] J. Cleland,et al. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[7] S. Gottlieb,et al. B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. , 2006, American heart journal.
[8] N. Ohte,et al. Single beat determination of regional myocardial strain measurements in patients with atrial fibrillation. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[9] H. Morita,et al. Coronary Reperfusion Therapy in STEMI Patients : Global Standard and Unsolved Issues(Morning Lecture 10 (ML10) (IHD),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) , 2006 .
[10] H. Okura,et al. Tissue Doppler-derived index of left ventricular filling pressure, E/E′, predicts survival of patients with non-valvular atrial fibrillation , 2006, Heart.
[11] M. Elnoamany,et al. Mitral annular motion as a surrogate for left ventricular function: correlation with brain natriuretic peptide levels. , 2005, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[12] N. Lee,et al. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[13] I. Takeuchi,et al. Distinguishable optimal levels of plasma B-type natriuretic peptide in heart failure management based on complicated atrial fibrillation. , 2005, International heart journal.
[14] D. Levy,et al. Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.
[15] W. Gaasch,et al. Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle. , 2004, The New England journal of medicine.
[16] J. Seward,et al. The changing epidemiology and natural history of nonvalvular atrial fibrillation: clinical implications. , 2004, Transactions of the American Clinical and Climatological Association.
[17] James D. Thomas,et al. Determinants of LV diastolic function during atrial fibrillation: beat-to-beat analysis in acute dog experiments. , 2004, American journal of physiology. Heart and circulatory physiology.
[18] Y. Onose,et al. Mitral inflow and mitral annular motion velocities in patients with mitral annular calcification: evaluation by pulsed Doppler echocardiography and pulsed Doppler tissue imaging. , 2002, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[19] RudolfBerger,et al. B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002 .
[20] L. Morrison,et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. , 2002, Annals of emergency medicine.
[21] S. Ommen,et al. Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures: A Comparative Simultaneous Doppler-Catheterization Study , 2000, Circulation.
[22] H. S. Kim,et al. Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation. , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[23] M. Quiñones,et al. Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging. , 1998, Circulation.
[24] M. Kinoshita,et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. , 1998, American heart journal.
[25] T. Wakatsuki,et al. Evaluation of left atrial filling using systolic pulmonary venous flow velocity measurements in patients with atrial fibrillation , 1998, Clinical cardiology.
[26] E. Suzuki,et al. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. , 1995, American heart journal.
[27] K. Nakao,et al. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure. , 1994, British heart journal.
[28] W. Edwards,et al. Natriuretic peptide system in human heart failure. , 1993, Circulation.
[29] N. Schiller,et al. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. , 1990, The American journal of cardiology.
[30] C Kawai,et al. Myocardial relaxation in atrial fibrillation. , 1986, Journal of the American College of Cardiology.
[31] N Reichek,et al. Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.